<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35171059</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Wasp venom from <i>Vespa magnifica</i> acts as a neuroprotective agent to alleviate neuronal damage after stroke in rats.</ArticleTitle>
        <Pagination>
          <StartPage>334</StartPage>
          <EndPage>346</EndPage>
          <MedlinePgn>334-346</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2032207</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Acute ischaemic stroke (AIS) is a major cause of disability and death, which is a serious threat to human health and life. Wasp venom extracted from <i>Vespa magnifica</i> Smith (Vespidae) could treat major neurological disorders.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study investigated the effects of wasp venom on AIS in rats.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We used a transient middle cerebral artery occlusion (MCAO) model in Sprague-Dawley rats (260-280 g, <i>n</i> = 8-15) with a sham operation group being treated as negative control. MCAO rats were treated with wasp venom (0.05, 0.2 and 0.6 mg/kg, <i>i.p.</i>) using intraperitoneal injection. After treatment 48 h, behavioural tests, cortical blood flow (CBF), TTC staining, H&amp;E staining, Nissl staining, TUNEL assay, immunohistochemistry (IHC) and ELISA were employed to investigate neuroprotective effects of wasp venom.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the MCAO group, wasp venom (0.6 mg/kg) improved neurological impairment, accelerated CBF recovery (205.6 ± 52.92 <i>versus</i> 216.7 ± 34.56), reduced infarct volume (337.1 ± 113.2 <i>versus</i> 140.7 ± 98.03) as well as BBB permeability as evidenced by changes in claudin-5 and AQP4. In addition, function recovery of stroke by wasp venom treatment was associated with a decrease in TNF-α, IL-1β, IL-6 and inhibition activated microglia as well as apoptosis. Simultaneously, the wasp venom regulated the angiogenesis factors VEGF and b-FGF in the brain.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Wasp venom exhibited a potential neuroprotective effect for AIS. In the future, we will focus on determining whether the observed actions were due to a single compound or the interaction of multiple components of the venom.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Hairong</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0003-0000-8136</Identifier>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Xiamen University, Xiamen, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Mei</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiumei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National-Local Joint Engineering Research Center of Entomoceutics, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Huai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National-Local Joint Engineering Research Center of Entomoceutics, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Fanmao</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Jiaming</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Xiamen University, Xiamen, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Jidong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Xiamen University, Xiamen, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National-Local Joint Engineering Research Center of Entomoceutics, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chenggui</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-2691-5079</Identifier>
            <AffiliationInfo>
              <Affiliation>Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&amp;D, Dali University, Dali, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National-Local Joint Engineering Research Center of Entomoceutics, Dali, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014862">Wasp Venoms</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020244" MajorTopicYN="N">Infarction, Middle Cerebral Artery</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014862" MajorTopicYN="N">Wasp Venoms</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014863" MajorTopicYN="N">Wasps</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ischaemic stroke</Keyword>
        <Keyword MajorTopicYN="N">brain–blood barrier</Keyword>
        <Keyword MajorTopicYN="N">neuroinflammation</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>12</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35171059</ArticleId>
        <ArticleId IdType="pmc">PMC8863380</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2032207</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abbott NJ, Rönnbäck L, Hansson E.. 
2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 7(1):41–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16371949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amara SG.
1992. Neurotransmitter transporters. A tale of two families. Nature. 360(6403):420–421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1333057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arai K, Jin G, Navaratna D, Lo EH.. 
2009. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 276(17):4644–4652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3712842</ArticleId>
            <ArticleId IdType="pubmed">19664070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araki N, Greenberg JH, Sladky JT, Uematsu D, Karp A, Reivich M.. 
1992. The effect of hyperglycemia on intracellular calcium in stroke. J Cereb Blood Flow Metab. 12(3):469–476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1569140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Badawi HM, Abdelsalam RM, Abdel-Salam OM, Youness ER, Shaffie NM, Eldenshary EDS.. 
2020. Bee venom attenuates neurodegeneration and motor impairment and modulates the response to L-dopa or rasagiline in a mice model of Parkinson's disease. Iran J Basic Med Sci. 23(12):1628–1638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7811814</ArticleId>
            <ArticleId IdType="pubmed">33489038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron JC.
1999. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 9(4):193–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10393405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogousslavsky J.
1991. Topographic patterns of cerebral infarcts. Cerebrovasc Dis. 1(1):61–68.</Citation>
        </Reference>
        <Reference>
          <Citation>Cai M, Choi SM, Yang EJ.. 
2015. The effects of bee venom acupuncture on the central nervous system and muscle in an animal hSOD1G93A mutant. Toxins (Basel). 7(3):846–858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4379529</ArticleId>
            <ArticleId IdType="pubmed">25781653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD.. 
1986. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 17(4):738–743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2943059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Liu L.. 
2012. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 64(7):640–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22154620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung ES, Kim H, Lee G, Park S, Kim H, Bae H.. 
2012. Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: role of regulatory T cells. Brain Behav Immun. 26(8):1322–1330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22974722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danielisova V, Gottlieb M, Nemethova M, Burda J.. 
2008. Effects of bradykinin postconditioning on endogenous antioxidant enzyme activity after transient forebrain ischemia in rat. Neurochem Res. 33(6):1057–1064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18080186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danielisova V, Gottlieb M, Nemethova M, Kravcukova P, Domorakova I, Mechirova E, Burda J.. 
2009. Bradykinin postconditioning protects pyramidal CA1 neurons against delayed neuronal death in rat hippocampus. Cell Mol Neurobiol. 29(6–7):871–878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19259804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C.. 
2016. Thromboinflammation in stroke brain damage. Stroke. 47(4):1165–1172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26786115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C.. 
2012. von Willebrand factor: an emerging target in stroke therapy. Stroke. 43(2):599–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4102321</ArticleId>
            <ArticleId IdType="pubmed">22180250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Rooij NK, Greving JP, Rinkel GJ, Frijns CJ.. 
2013. Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke. 44(5):1288–1294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23512975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Docagne F, Parcq J, Lijnen R, Ali C, Vivien D.. 
2015. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke. Stroke. 46(1):314–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25395410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, et al. . 
2014. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 384(9958):1929–1935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4441266</ArticleId>
            <ArticleId IdType="pubmed">25106063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enomoto M, Endo A, Yatsushige H, Fushimi K, Otomo Y.. 
2019. Clinical effects of early edaravone use in acute ischemic stroke patients treated by endovascular reperfusion therapy. Stroke. 50(3):652–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30741623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, Group S, STAIR Group 
2009. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 40(6):2244–2250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2888275</ArticleId>
            <ArticleId IdType="pubmed">19246690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG.. 
2009. Does neuroinflammation fan the flame in neurodegenerative diseases?
Mol Neurodegener. 4:47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2784760</ArticleId>
            <ArticleId IdType="pubmed">19917131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Y, Yu WX, Duan XM, Ni LL, Liu H, Zhao HR, Xiao H, Zhang CG, Yang ZB.. 
2020. Wasp venom possesses potential therapeutic effect in experimental models of rheumatoid arthritis. Evid Based Complement Alternat Med. 2020:6394625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7165351</ArticleId>
            <ArticleId IdType="pubmed">32328136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giaume C, Koulakoff A, Roux L, Holcman D, Rouach N.. 
2010. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci. 11(2):87–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20087359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginsberg MD, Pulsinelli WA.. 
1994. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol. 36(4):553–554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7944286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grotta J, Ackerman R, Correia J, Fallick G, Chang J.. 
1982. Whole blood viscosity parameters and cerebral blood flow. Stroke. 13(3):296–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7080121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et al. . 
2008. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 359(13):1317–1329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18815396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hakim AM.
1987. The cerebral ischemic penumbra. Can J Neurol Sci. 14(4):557–559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2446732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herz J, Hagen SI, Bergmuller E, Sabellek P, Gothert JR, Buer J, Hansen W, Hermann DM, Doeppner TR.. 
2014. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis. 62:456–468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24184800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirt L, Fukuda AM, Ambadipudi K, Rashid F, Binder D, Verkman A, Ashwal S, Obenaus A, Badaut J.. 
2017. Improved long-term outcome after transient cerebral ischemia in aquaporin-4 knockout mice. J Cereb Blood Flow Metab. 37(1):277–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5363745</ArticleId>
            <ArticleId IdType="pubmed">26767580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Y, Zhao H, Lu J, Xie D, Wang Q, Huang T, Xin H, Hisatome I, Yamamoto T, Wang W, et al. . 
2021. High uric acid promotes dysfunction in pancreatic β cells by blocking IRS2/AKT signalling. Mol Cell Endocrinol. 520:111070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33127482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, et al. . 
2013. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 44(3):870–947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23370205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin R, Yang G, Li G.. 
2010. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 87(5):779–789.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2858674</ArticleId>
            <ArticleId IdType="pubmed">20130219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones S, Howl J.. 
2012. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide. Bioconjug Chem. 23(1):47–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22148546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalil WK, Assaf N, ElShebiney SA, Salem NA.. 
2015. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem Int. 80:79–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25481089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim ME, Lee JY, Lee KM, Park HR, Lee E, Lee Y, Lee JS, Lee J.. 
2016. Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease. Arch Pharm Res. 39(8):1160–1170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27469335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G.. 
2007. Targeting platelets in acute experimental stroke. Circulation. 115(17):2323–2330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17438148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi S, Fukuma S, Ikenoue T, Fukuhara S, Kobayashi S.. 
2019. Effect of edaravone on neurological symptoms in real-world patients with acute ischemic stroke. Stroke. 50(7):1805–1811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31164072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM.. 
1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 25(9):1794–1798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7521076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuge Y, Minematsu K, Yamaguchi T, Miyake Y.. 
1995. Nylon monofilament for intraluminal middle cerebral-artery occlusion in rats. Stroke. 26(9):1655–1657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7660413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, Hopkins LN, Mocco J.. 
2009. First food and drug administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 40(11):3552–3556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19696415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li RY, Cao ZG, Li Y, Wang RT.. 
2015. Increased whole blood viscosity is associated with silent cerebral infarction. Clin Hemorheol Microcirc. 59(4):301–307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23988733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, Hug A, Zorn M, Dalpke A, Nawroth P, et al. . 
2009. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 40(8):2849–2858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19443795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipton P.
1999. Ischemic cell death in brain neurons. Physiol Rev. 79(4):1431–1568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10508238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu F, McCullough LD.. 
2011. Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol. 2011:464701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3035178</ArticleId>
            <ArticleId IdType="pubmed">21331357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo EH, Dalkara T, Moskowitz MA.. 
2003. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 4(5):399–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12728267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Longa EZ, Weinstein PR, Carlson S, Cummins R.. 
1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20(1):84–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2643202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Low PC, Manzanero S, Mohannak N, Narayana VK, Nguyen TH, Kvaskoff D, Brennan FH, Ruitenberg MJ, Gelderblom M, Magnus T, et al. . 
2014. PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model. Nat Commun. 5(1):12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24625684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY.. 
2007. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol. 7(8):1092–1101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17570326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A.. 
2005. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 99(1):6–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16177542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mortari MR, Cunha AO, de Oliveira L, Vieira EB, Gelfuso EA, Coutinho-Netto J, Ferreira dos Santos W.. 
2005. Anticonvulsant and behavioural effects of the denatured venom of the social wasp Polybia occidentalis (Polistinae, Vespidae). Basic Clin Pharmacol Toxicol. 97(5):289–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16236140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moskowitz MA, Lo EH, Iadecola C.. 
2010. The science of stroke: mechanisms in search of treatments. Neuron. 67(2):181–198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2957363</ArticleId>
            <ArticleId IdType="pubmed">20670828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nayak D, Roth TL, McGavern DB.. 
2014. Microglia development and function. Annu Rev Immunol. 32(1):367–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5001846</ArticleId>
            <ArticleId IdType="pubmed">24471431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S.. 
2003. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice. J Cell Biol. 161(3):653–660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2172943</ArticleId>
            <ArticleId IdType="pubmed">12743111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, Ifuku M, Kosai Y, Wang B, Nolte C, et al. . 
2007. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 101(2):397–410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17402969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O-Uchi T, Tanaka Y.. 
1988. Study of the so-called cochlear mechanical tinnitus. Acta Oto-Laryngol. 105(447):94–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3188900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J.. 
2007. Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology. 49(2):93–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1786189</ArticleId>
            <ArticleId IdType="pubmed">17177065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereda AE.
2014. Electrical synapses and their functional interactions with chemical synapses. Nat Rev Neurosci. 15(4):250–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4091911</ArticleId>
            <ArticleId IdType="pubmed">24619342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry VH, Nicoll JAR, Holmes C.. 
2010. Microglia in neurodegenerative disease. Nat Rev Neurol. 6(4):193–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20234358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rádis-Baptista G.
2021. Cell-penetrating peptides derived from animal venoms and toxins. Toxins. 13(2):147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7919042</ArticleId>
            <ArticleId IdType="pubmed">33671927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren X, Hu H, Farooqi I, Simpkins JW.. 
2020. Blood substitution therapy rescues the brain of mice from ischemic damage. Nat Commun. 11(1):4078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7447645</ArticleId>
            <ArticleId IdType="pubmed">32843630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saba E, Shafeeq T, Irfan M, Lee YY, Kwon HW, Seo MG, Park SJ, Lee KY, Rhee MH.. 
2017. Anti-inflammatory activity of crude venom isolated from parasitoid wasp, bracon hebetor say. Mediat Inflamm. 2017:6978194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5682083</ArticleId>
            <ArticleId IdType="pubmed">29213193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, Sekiya T, Ooboshi H, Kitazono T, Yanagawa T, et al. . 
2012. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med. 18(6):911–917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22610280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, et al. . 
2009. Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat Med. 15(8):946–950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19648929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V.. 
2007. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 6(3):258–268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2725365</ArticleId>
            <ArticleId IdType="pubmed">17303532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song YM.
2011. Topographic patterns of thalamic infarcts in association with stroke syndromes and aetiologies. J Neurol Neurosurg Psychiatry. 82(10):1083–1086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21406535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sternberg EM.
2006. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol. 6(4):318–328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1783839</ArticleId>
            <ArticleId IdType="pubmed">16557263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su Y, Zhang L, Zhou Y, Ding L, Li L, Wang Z.. 
2021. The progress of research on histone methylation in ischemic stroke pathogenesis. J Physiol Biochem. DOI: 10.1007/s13105-021-00841-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13105-021-00841-w</ArticleId>
            <ArticleId IdType="pubmed">34472033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thathiah A, De Strooper B.. 
2011. The role of G protein-coupled receptors in the pathology of Alzheimer’s disease. Nat Rev Neurosci. 12(2):73–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21248787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tobin MK, Bonds JA, Minshall RD, Pelligrino DA, Testai FD, Lazarov O.. 
2014. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J Cereb Blood Flow Metab. 34(10):1573–1584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4269726</ArticleId>
            <ArticleId IdType="pubmed">25074747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner RC, Dodson SC, Rosen CL, Huber JD.. 
2013. The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J Neurosurg. 118(5):1072–1085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4652647</ArticleId>
            <ArticleId IdType="pubmed">23331000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Hayashi T, Chang CF, Chiang YH, Tsao LI, Su TP, Borlongan C, Lin SZ.. 
2001. Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke. 32(3):775–782.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11239201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warach S, Latour LL.. 
2004. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 35(1):2659–2661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15472105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G.. 
2012. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 379(9834):2364–2372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3386494</ArticleId>
            <ArticleId IdType="pubmed">22632907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al. . 
2019. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 18(4):394–405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30878104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu AD, Wang YJ, Wang DZ, Expert CST.. 
2013. Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese stroke therapy expert panel. CNS Neurosci Ther. 19(8):543–548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6493470</ArticleId>
            <ArticleId IdType="pubmed">23710819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang EJ, Jiang JH, Lee SM, Yang SC, Hwang HS, Lee MS, Choi SM.. 
2010. Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflammation. 7:69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2974667</ArticleId>
            <ArticleId IdType="pubmed">20950451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang XM, Du F, Yang D, Yu CJ, Huang XN, Liu W, Fu J.. 
2010. Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke. BMC Neurosci. 11:138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2974740</ArticleId>
            <ArticleId IdType="pubmed">20973978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang YM, Qu XY, Tao LN, Zhai JH, Gao H, Song YQ, Zhang SX.. 
2020. XingNaoJing injection ameliorates cerebral ischaemia/reperfusion injury via SIRT1-mediated inflammatory response inhibition. Pharm Biol. 58(1):16–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6968491</ArticleId>
            <ArticleId IdType="pubmed">31854225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZG, Chopp M.. 
2015. Promoting brain remodeling to aid in stroke recovery. Trends Mol Med. 21(9):543–548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4567429</ArticleId>
            <ArticleId IdType="pubmed">26278490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M.. 
2002. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 22(4):379–392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11919509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou ST, Luan K, Ni LL, Wang Y, Yuan SM, Che YH, Yang ZZ, Zhang CG, Yang ZB.. 
2019. A strategy for quality control of vespa magnifica (Smith) venom based on HPLC fingerprint analysis and multi-component separation combined with quantitative analysis. Molecules. 24(16):2920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6719070</ArticleId>
            <ArticleId IdType="pubmed">31408988</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
